Pages that link to "Q33792844"
Jump to navigation
Jump to search
The following pages link to The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies (Q33792844):
Displaying 50 items.
- Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis (Q27653667) (← links)
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates (Q27653843) (← links)
- Structure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidis (Q27674699) (← links)
- Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen (Q27676318) (← links)
- Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity (Q28730934) (← links)
- Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein (Q30157650) (← links)
- Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis (Q30159962) (← links)
- A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups (Q33418169) (← links)
- Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter. (Q33614888) (← links)
- The modular architecture of meningococcal factor H-binding protein (Q33809048) (← links)
- Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor h binding (Q33962709) (← links)
- Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies (Q34529441) (← links)
- Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody (Q34661129) (← links)
- Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate (Q34720425) (← links)
- A Meningococcal Factor H Binding Protein Mutant That Eliminates Factor H Binding Enhances Protective Antibody Responses to Vaccination (Q34993283) (← links)
- Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii (Q35015181) (← links)
- Novel Blocking Human IgG Directed against the Pentapeptide Repeat Motifs of Neisseria meningitidis Lip/H.8 and Laz Lipoproteins (Q35075181) (← links)
- Complement-Mediated Bactericidal Activity of Anti-Factor H Binding Protein Monoclonal Antibodies against the Meningococcus Relies upon Blocking Factor H Binding (Q35191862) (← links)
- A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens (Q35658277) (← links)
- Combined Roles of Human IgG Subclass, Alternative Complement Pathway Activation, and Epitope Density in the Bactericidal Activity of Antibodies to Meningococcal Factor H Binding Protein (Q35665404) (← links)
- Molecular Engineering of Ghfp, the Gonococcal Orthologue of Neisseria meningitidis Factor H Binding Protein (Q35773926) (← links)
- Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein (Q35777766) (← links)
- A broadly cross-reactive monoclonal antibody against an epitope on the n-terminus of meningococcal fHbp. (Q35857593) (← links)
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens (Q35989852) (← links)
- A universal vaccine for serogroup B meningococcus (Q36101910) (← links)
- Towards an improved serogroup B Neisseria meningitidis vaccine (Q36327065) (← links)
- The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance (Q36470692) (← links)
- Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870 (Q36638451) (← links)
- Type VI secretion system sheaths as nanoparticles for antigen display (Q36710694) (← links)
- Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines (Q36710765) (← links)
- Cellulose-bound peptide arrays: preparation and applications (Q37024675) (← links)
- Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines (Q37037083) (← links)
- Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity (Q37163679) (← links)
- Serogroup B meningococcal vaccines-an unfinished story (Q37683962) (← links)
- Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics. (Q38161994) (← links)
- Variation of the factor H-binding protein of Neisseria meningitidis (Q38350786) (← links)
- Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen. (Q38363907) (← links)
- Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading (Q39830636) (← links)
- Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccines (Q40023741) (← links)
- Synthesis and immunological evaluation of protein conjugates of Neisseria meningitidis X capsular polysaccharide fragments (Q41669855) (← links)
- Structural organization of NadADelta(351-405), a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level (Q43455107) (← links)
- Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B. (Q44695129) (← links)
- Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines. (Q45991649) (← links)
- Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease. (Q46027898) (← links)
- Factor H-binding protein, a unique meningococcal vaccine antigen (Q47957684) (← links)
- Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp. (Q48095992) (← links)
- Neisseria Heparin Binding Antigen is targeted by the human alternative pathway C3-convertase. (Q52631109) (← links)
- Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes. (Q52682421) (← links)
- Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus. (Q54329423) (← links)
- Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection (Q61293682) (← links)